BULENT OZPOLAT to Drug Delivery Systems
This is a "connection" page, showing publications BULENT OZPOLAT has written about Drug Delivery Systems.
Connection Strength
0.668
-
Liposomal cytokines and liposomes targeted to costimulatory molecules as adjuvants for human immunodeficiency virus subunit vaccines. Methods Enzymol. 2003; 373:92-100.
Score: 0.162
-
Delivery of Small Molecule EF2 Kinase Inhibitor for Breast and Pancreatic Cancer Cells Using Hyaluronic Acid Based Nanogels. Pharm Res. 2020 Mar 04; 37(3):63.
Score: 0.133
-
Hyaluronic acid and hyaluronic acid: Sucrose nanogels for hydrophobic cancer drug delivery. Int J Biol Macromol. 2019 Apr 01; 126:1150-1157.
Score: 0.123
-
Targeted Therapies for Pancreatic Cancer and Hurdles Ahead. Anticancer Res. 2018 Dec; 38(12):6591-6606.
Score: 0.122
-
Nanotechnology in cancer therapy. J Drug Target. 2013 Dec; 21(10):904-13.
Score: 0.085
-
Oligonucleotide-based theranostic nanoparticles in cancer therapy. Nanomedicine (Lond). 2016 05; 11(10):1287-308.
Score: 0.025
-
Targeting p70S6K prevented lung metastasis in a breast cancer xenograft model. Mol Cancer Ther. 2010 May; 9(5):1180-7.
Score: 0.017